Topic: Johnson & Stricker- how IDSA became entangled with antitrust
Tincup
Honored Contributor (10K+ posts)
Member # 5829
posted
Strung up, strung out or simply entangled?
Johnson & Stricker lay down the law on how IDSA became entangled with antitrust.
21 May
Some more light reading for those late nights when nothing in on the tube and you're wondering how IDSA got ensnared in antitrust law with its Lyme disease guidelines.
Just how flawed was its guidelines development process?
Why is it important to democracy that opposing viewpoints be heard before vital freedoms--like your ability to choose among treatment options--are taken away.
When do medical society have an obligation to not suppress legitimate medical controversy?
And, what is the drill for the settlement process anyway?
If you have comments on the article, send them to me at [email protected]
posted
i can't read TIMESNEWROMAN so have copied this brief article below and breaking it up for us neuros to read/comprehend.
If you have comments on the article, send them to me at [email protected] ***************************************
Journal of Medical Ethics 2009;35:283-288; doi:10.1136/jme.2008.026526
Copyright � 2009 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.
Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process
1 California Lyme Disease Association, Ukiah, California, USA
2 International Lyme and Associated Diseases Society, Bethesda, Maryland, USA
Correspondence to:
Dr R B Stricker, 450 Sutter Street, Suite 1504, San Francisco, California 94108, USA; [email protected]
Lyme disease is one of the most controversial illnesses in the history of medicine.
In 2006 the Connecticut Attorney General launched an antitrust investigation into the Lyme guidelines development process of the Infectious Diseases Society of America (IDSA).
In a recent settlement with IDSA, the Attorney General noted important commercial conflicts of interest and suppression of scientific evidence that had tainted the guidelines process.
This paper explores two broad ethical themes that influenced the IDSA investigation.
The first is the growing problem of conflicts of interest among guidelines developers, and the second is the increasing centralisation of medical decisions by insurance companies, which use treatment guidelines as a means of controlling the practices of individual doctors and denying treatment for patients.
The implications of the first-ever antitrust investigation of medical guidelines and the proposed model to remediate the tainted IDSA guidelines process are also discussed.
**************
so their article did NOT show up; a brief summary? guess i'll email lorraine... betty
IP: Logged |
posted
Tincup- is it possible to see the full article on CALDA's website, I can't seem to find it... Thanks!
Posts: 371 | From CT | Registered: Jun 2008
| IP: Logged |
Tincup
Honored Contributor (10K+ posts)
Member # 5829
posted
JK..
I couldn't find the original article either... so I wrote to the authors and asked if it was somewhere (point it out) and could they direct me to it so it can be shared.
posted
btw, that site does not render correctly in IE 8, best to use firefox, google chrome, or an earlier verison of IE with it.
Posts: 526 | From NJ | Registered: May 2007
| IP: Logged |
bettyg
Unregistered
posted
it can be purchased from the site shown above ... british .....
IP: Logged |
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/
UBBFriend: Email this page to someone!
![[Big Grin]](biggrin.gif)
Printer-friendly view of this topic